One additional injection of insulin three hours after eating has been shown to protect people with type 1 diabetes from cardiovascular disease – the leading cause of death among people with the condition.
A small preliminary clinical trial published in Diabetes and Vascular Disease Research has found the easy step allows people with type 1 diabetes to better regulate their blood sugar levels.
The way type-2 diabetes is currently treated generates differences of opinion within the medical community. Whilst some favour a drug combination approach that could improve quality of life for patients and reduce costs, others are concerned about the risks and side effects of this strategy and support a step-by-step method whereby one drug is used at a time depending on how the patient responds.
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]) suggests that omega 3 polyunsaturated fatty acids (PUFAs), derived primarily from fish in maternal diet during pregnancy or lactation, may help protect infants at high risk of type 1 diabetes (T1D) from developing the disease.
The incidence of cardiovascular diseases in Sweden has decreased sharply since the late 1990s. These are the findings of a study from Sahlgrenska Academy which included almost three million adult Swedes. In relative terms, the biggest winners are persons with type 1 and type 2 diabetes.
“This is a huge improvement and a testament to the improvements in diabetes and cardiovascular care throughout Sweden,” says Aidin Rawshani, medical doctor and doctoral student in molecular and clinical medicine.
A new study from the University of Eastern Finland adds to the growing body of evidence indicating that the source of dietary protein may play a role in the risk of developing type 2 diabetes. The researchers found that plant protein was associated with a lower risk of type 2 diabetes, while persons with a diet rich in meat had a higher risk. The findings were published in the British Journal of Nutrition.
A new review investigates the effects of avocados on different components of metabolic syndrome, which is a clustering of risk factors including high blood sugar, cholesterol, blood pressure, and body mass index. These risk factors lead to an increased risk of type 2 diabetes and cardiovascular disease.